On group sequential designs comparing two binomial proportions

Journal of Biopharmaceutical Statistics

Volumn 20, Issue 1, 2010, Pages 145-159

  Kepner, James L ^a  

^a AMERICAN CANCER SOCIETY   (United States)

Author keywords

Efficacy; Exact test; Futility; Group sequential design; Phase II clinical trial; Phase III clinical trial; Size of a test; Statistical power

Indexed keywords

ALGORITHM; ARTICLE; BINOMIAL DISTRIBUTION; COMPUTER PROGRAM; GROUP SEQUENTIAL DESIGN; INTERMETHOD COMPARISON; METHODOLOGY; PRIORITY JOURNAL; SAMPLE SIZE; SEQUENTIAL ANALYSIS;

CLINICAL TRIALS, PHASE II AS TOPIC; CLINICAL TRIALS, PHASE III AS TOPIC; HUMANS; MODELS, STATISTICAL; RESEARCH DESIGN; SAMPLE SIZE;

EID: 75649146192     PISSN: 10543406     EISSN: 15205711     Source Type: Journal    
DOI: 10.1080/10543400903280621     Document Type: Article

References (9)

1. Barnard, G. A. (1947). Significance tests. Biometrika 34:123-138.
2. Chow, S. C., Shao, J., Wang, H. (2003). Sample Size Calculations in Clinical Research. New York: Marcel Dekker.
3. East Version 3.0 User Manual. (2003). Cambridge, MA: Cytel Software Corporation.
4. Hollander, M., Wolfe, D. A. (1999). Nonparametric Statistical Methods. New York: Wiley.
5. Jennison, C., Turnbull, B. W. (2000). Group Sequential Methods with Applications to Clinical Trials. Boca Raton, FL: Chapman and Hall/CRC.
6. Kepner, J. L., Chang, M. C. (2003). On the maximum total sample size of a group sequential test about binomial proportions. Statistics and Probability Letters 62:87-92.
7. Kepner, J. L., Chang, M. C. (2004). Samples of exact k-stage group sequential designs for phase II and pilot studies. Controlled Clinical Trials 25:326-333.
8. PASS 2008 User's Guide-I. (2008). Kaysville, UT: NCSS.
9. StatXact User Manual. (2004). Cambridge, MA: Cytel Software Corporation.